AzurRx BioPharma Initiates Phase 2 Clinical Trial For COVID-19 Treatment

Many symptoms of long-haul have been prevalent to respiratory ailments, that many tend to forget the ones that effect our stomachs. Studies are showing that the GI tract is a “silent reservoir” and doctors are trying to find an oral capsule to support a healthy gut and and clear the GI tract from COVID-19. The symptoms of COVID-19 that effect the stomach are:

·      Diarrhea

·      Vomiting

·      Abdominal pain

Due to this, there is some evidence that support the idea and nothing that the GI tract is a possible reservoir for recurrence and even the spread of COVID-19 virus.

To read the full article Click Here